Cited by 181Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingLysosomal Storage Disorders Research

BACE1 activity is modulated by cell-associated sphingosine-1-phosphate

Open access
Takasugi, Nobumasa, Sasaki, Tomoki, Suzuki, Kunimichi, Osawa, Satoko, Isshiki, Hayato, Hori, Yukiko, Shimada, Naoaki, Higo, Takuya +6 more·2011·The Journal of Neuroscience

Abstract

Sphingosine kinase (SphK) 1 and 2 phosphorylate sphingosine to generate sphingosine-1-phosphate (S1P), a pluripotent lipophilic mediator implicated in a variety of cellular events. Here we show that the activity of β-site APP cleaving enzyme-1 (BACE1), the rate-limiting enzyme for amyloid-β peptide (Aβ) production, is modulated by S1P in mouse neurons. Treatment by SphK inhibitor, RNA interference knockdown of SphK, or overexpression of S1P degrading enzymes decreased BACE1 activity, which reduced Aβ production. S1P specifically bound to full-length BACE1 and increased its proteolytic activity, suggesting that cellular S1P directly modulates BACE1 activity. Notably, the relative activity of SphK2 was upregulated in the brains of patients with Alzheimer's disease. The unique modulatory effect of cellular S1P on BACE1 activity is a novel potential therapeutic target for Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.6467-10.2011

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 53

  1. Ahmed RR Holler CJ Webb RL Li F Beckett TL Murphy MP 2010 BACE1 and BACE2 enzymatic activities in Alzheimer’s disease J Neurochem 112 1045 1053 19968762 PMC2819564
  2. Alvarez SE Milstien S Spiegel S 2007 Autocrine and paracrine roles of sphingosine-1-phosphate Trends Endocrinol Metab 18 300 307 17904858
  3. Alvarez SE Harikumar KB Hait NC Allegood J Strub GM Kim EY Maceyka M Jiang H Luo C Kordula T Milstien S Spiegel S 2010 Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 Nature 465 1084 1088 20577214 PMC2946785
  4. Arnold SE Lee EB Moberg PJ Stutzbach L Kazi H Han LY Lee VM Trojanowski JQ 2010 Olfactory epithelium amyloid-β and paired helical filament-tau pathology in Alzheimer disease Ann Neurol 67 462 469 20437581 PMC2864948
  5. Blondeau N Lai Y Tyndall S Popolo M Topalkara K Pru JK Zhang L Kim H Liao JK Ding K Waeber C 2007 Distribution of sphingosine kinase activity and mRNA in rodent brain J Neurochem 103 509 517 17623044 PMC2639651
  6. Cai H Wang Y McCarthy D Wen H Borchelt DR Price DL Wong PC 2001 BACE1 is the major beta-secretase for generation of Aβ peptides by neurons Nat Neurosci 4 233 234 11224536
  7. Chow VW Savonenko AV Melnikova T Kim H Price DL Li T Wong PC 2010 Modeling an anti-amyloid combination therapy for Alzheimer’s disease Sci Transl Med 2 13ra11 PMC2852193 20371462
  8. Darios F Wasser C Shakirzyanova A Giniatullin A Goodman K Munoz-Bravo JL Raingo J Jorgacevski J Kreft M Zorec R Rosa JM Gandia L Gutierrez LM Binz T Giniatullin R Kavalali ET Davletov B 2009 Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis Neuron 62 683 694 19524527 PMC2697323
  9. De Strooper B Vassar R Golde T 2010 The secretases: enzymes with therapeutic potential in Alzheimer disease Nat Rev Neurol 6 99 107 20139999 PMC2879045
  10. Don AS Martinez-Lamenca C Webb WR Proia RL Roberts E Rosen H 2007 Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues J Biol Chem 282 15833 15842 17400555
  11. French KJ Schrecengost RS Lee BD Zhuang Y Smith SN Eberly JL Yun JK Smith CD 2003 Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Res 63 5962 5969 14522923
  12. French KJ Upson JJ Keller SN Zhuang Y Yun JK Smith CD 2006 Antitumor activity of sphingosine kinase inhibitors J Pharmacol Exp Ther 318 596 603 16632640
  13. French KJ Zhuang Y Maines LW Gao P Wang W Beljanski V Upson JJ Green CL Keller SN Smith CD 2010 Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2 J Pharmacol Exp Ther 333 129 139 20061445 PMC2846016
  14. Fukumoto H Tomita T Matsunaga H Ishibashi Y Saido TC Iwatsubo T 1999 Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid β peptides ending at Aβ40 and Aβ42 Neuroreport 10 2965 2969 10549806
  15. Fukumoto H Cheung BS Hyman BT Irizarry MC 2002 β-secretase protein and activity are increased in the neocortex in Alzheimer disease Arch Neurol 59 1381 1389 12223024
  16. Fukumoto H Takahashi H Tarui N Matsui J Tomita T Hirode M Sagayama M Maeda R Kawamoto M Hirai K Terauchi J Sakura Y Kakihana M Kato K Iwatsubo T Miyamoto M 2010 A noncompetitive BACE1 inhibitor TAK-070 ameliorates Aβ pathology and behavioral deficits in a mouse model of Alzheimer’s disease J Neurosci 30 11157 11166 20720123 PMC6633483
  17. Hait NC Bellamy A Milstien S Kordula T Spiegel S 2007 Sphingosine kinase type 2 activation by ERK-mediated phosphorylation J Biol Chem 282 12058 12065 17311928
  18. Hait NC Allegood J Maceyka M Strub GM Harikumar KB Singh SK Luo C Marmorstein R Kordula T Milstien S Spiegel S 2009 Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate Science 325 1254 1257 19729656 PMC2850596
  19. Hashimoto T Wakabayashi T Watanabe A Kowa H Hosoda R Nakamura A Kanazawa I Arai T Takio K Mann DM Iwatsubo T 2002 CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV Embo J 21 1524 1534 11927537 PMC125364
  20. Hempen B Brion JP 1996 Reduction of acetylated α-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer’s disease J Neuropathol Exp Neurol 55 964 972 8800092
  21. Hori Y Hashimoto T Wakutani Y Urakami K Nakashima K Condron MM Tsubuki S Saido TC Teplow DB Iwatsubo T 2007 The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Aβ fibril formation without increasing protofibril formation J Biol Chem 282 4916 4923 17170111
  22. Hu X Hicks CW He W Wong P Macklin WB Trapp BD Yan R 2006 Bace1 modulates myelination in the central and peripheral nervous system Nat Neurosci 9 1520 1525 17099708
  23. Kalvodova L Kahya N Schwille P Ehehalt R Verkade P Drechsel D Simons K 2005 Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro J Biol Chem 280 36815 36823 16115865
  24. Kan T Tominari Y Morohashi Y Natsugari H Tomita T Iwatsubo T Fukuyama T 2003 Solid-phase synthesis of photoaffinity probes: highly efficient incorporation of biotin-tag and cross-linking groups Chem Commun (Camb) 2244 2245 13678222
  25. Kawashima N Yoon SJ Itoh K Nakayama K 2009 Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions J Biol Chem 284 6147 6155 19124464
  26. Kihara A Ikeda M Kariya Y Lee EY Lee YM Igarashi Y 2003 Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm J Biol Chem 278 14578 14585 12584204
  27. Laird FM Cai H Savonenko AV Farah MH He K Melnikova T Wen H Chiang HC Xu G Koliatsos VE Borchelt DR Price DL Lee HK Wong PC 2005 BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions J Neurosci 25 11693 11709 16354928 PMC2564291
  28. Li R Lindholm K Yang LB Yue X Citron M Yan R Beach T Sue L Sabbagh M Cai H Wong P Price D Shen Y 2004 Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer’s disease patients Proc Natl Acad Sci U S A 101 3632 3637 14978286 PMC373514
  29. Liu H Toman RE Goparaju SK Maceyka M Nava VE Sankala H Payne SG Bektas M Ishii I Chun J Milstien S Spiegel S 2003 Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis J Biol Chem 278 40330 40336 12835323
  30. Luo Y Bolon B Kahn S Bennett BD Babu-Khan S Denis P Fan W Kha H Zhang J Gong Y Martin L Louis JC Yan Q Richards WG Citron M Vassar R 2001 Mice deficient in BACE1, the Alzheimer’s β-secretase, have normal phenotype and abolished β-amyloid generation Nat Neurosci 4 231 232 11224535
  31. Maceyka M Sankala H Hait NC Le Stunff H Liu H Toman R Collier C Zhang M Satin LS Merrill AH Jr Milstien S Spiegel S 2005 SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J Biol Chem 280 37118 37129 16118219
  32. Mizugishi K Yamashita T Olivera A Miller GF Spiegel S Proia RL 2005 Essential role for sphingosine kinases in neural and vascular development Mol Cell Biol 25 11113 11121 16314531 PMC1316977
  33. Mutoh T Tokuda A Miyadai T Hamaguchi M Fujiki N 1995 Ganglioside GM1 binds to the Trk protein and regulates receptor function Proc Natl Acad Sci U S A 92 5087 5091 7539142 PMC41853
  34. Olivera A Urtz N Mizugishi K Yamashita Y Gilfillan AM Furumoto Y Gu H Proia RL Baumruker T Rivera J 2006 IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses J Biol Chem 281 2515 2525 16316995
  35. Pyne NJ Pyne S 2010 Sphingosine 1-phosphate and cancer Nat Rev Cancer 10 489 503 20555359
  36. Rajendran L Schneider A Schlechtingen G Weidlich S Ries J Braxmeier T Schwille P Schulz JB Schroeder C Simons M Jennings G Knolker HJ Simons K 2008 Efficient inhibition of the Alzheimer’s disease β-secretase by membrane targeting Science 320 520 523 18436784
  37. Reiss U Oskouian B Zhou J Gupta V Sooriyakumaran P Kelly S Wang E Merrill AH Jr Saba JD 2004 Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis J Biol Chem 279 1281 1290 14570870
  38. Schwab SR Pereira JP Matloubian M Xu Y Huang Y Cyster JG 2005 Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients Science 309 1735 1739 16151014
  39. Spiegel S Milstien S 2007 Functions of the multifaceted family of sphingosine kinases and some close relatives J Biol Chem 282 2125 2129 17135245
  40. Sumioka A Yan D Tomita S TARP phosphorylation regulates synaptic AMPA receptors through lipid bilayers Neuron 66 755 767 20547132 PMC2887694
  41. Takabe K Paugh SW Milstien S Spiegel S 2008 “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets Pharmacol Rev 60 181 195 18552276 PMC2695666
  42. Takasugi N Tomita T Hayashi I Tsuruoka M Niimura M Takahashi Y Thinakaran G Iwatsubo T 2003 The role of presenilin cofactors in the γ-secretase complex Nature 422 438 441 12660785
  43. Tesco G Koh YH Kang EL Cameron AN Das S Sena-Esteves M Hiltunen M Yang SH Zhong Z Shen Y Simpkins JW Tanzi RE 2007 Depletion of GGA3 stabilizes BACE and enhances β-secretase activity Neuron 54 721 737 17553422 PMC1973166
  44. Tomita T Maruyama K Saido TC Kume H Shinozaki K Tokuhiro S Capell A Walter J Grunberg J Haass C Iwatsubo T Obata K 1997 The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue Proc Natl Acad Sci U S A 94 2025 2030 9050898 PMC20036
  45. Tomita T Takikawa R Koyama A Morohashi Y Takasugi N Saido TC Maruyama K Iwatsubo T 1999 C terminus of presenilin is required for overproduction of amyloidogenic Aβ42 through stabilization and endoproteolysis of presenilin J Neurosci 19 10627 10634 10594046 PMC6784929
  46. Tomita T 2009 Secretase inhibitors and modulators for Alzheimer’s disease treatment Expert Rev Neurother 9 661 679 19402777
  47. Vetrivel KS Thinakaran G 2010 Membrane rafts in Alzheimer’s disease β-amyloid production Biochim Biophys Acta 1801 860 867 20303415 PMC2886169
  48. Wen Y Onyewuchi O Yang S Liu R Simpkins JW 2004 Increased β-secretase activity and expression in rats following transient cerebral ischemia Brain Res 1009 1 8 15120577
  49. Vassar R Kovacs DM Yan R Wong PC 2009 The beta-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential J Neurosci 29 12787 12794 19828790 PMC2879048
  50. Yamada K Yabuki C Seubert P Schenk D Hori Y Ohtsuki S Terasaki T Hashimoto T Iwatsubo T 2009 Aβ immunotherapy: intracerebral sequestration of Aβ by an anti-Aβ monoclonal antibody 266 with high affinity to soluble Aβ J Neurosci 29 11393 11398 19741145 PMC6665926
  51. Yang LB Lindholm K Yan R Citron M Xia W Yang XL Beach T Sue L Wong P Price D Li R Shen Y 2003 Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nat Med 9 3 4 12514700
  52. Yoshimoto T Furuhata M Kamiya S Hisada M Miyaji H Magami Y Yamamoto K Fujiwara H Mizuguchi J 2003 Positive modulation of IL-12 signaling by sphingosine kinase 2 associating with the IL-12 receptor beta 1 cytoplasmic region J Immunol 171 1352 1359 12874225
  53. Zemann B Kinzel B Muller M Reuschel R Mechtcheriakova D Urtz N Bornancin F Baumruker T Billich A 2006 Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720 Blood 107 1454 1458 16223773

Cited by

Sorted by citations

Authors
Takasugi, N., Sasaki, T., Suzuki, K., Osawa, S., Isshiki, H., Hori, Y., Shimada, N., Higo, T., Yokoshima, S., Fukuyama, T., Lee, V. M.-Y., Trojanowski, J. Q., Tomita, T., & Iwatsubo, T.
Affiliations
  • The University of Tokyo (JP)
  • University of Pennsylvania (US)
  • Japan Science and Technology Agency (JP)
Venue
The Journal of Neuroscience
Published
2011-05-04
Volume
31
Issue
18
Pages
6850-6857
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2041029999
Cited by
181
References
6
Citations by year
2026: 5 · 2025: 5 · 2024: 8 · 2023: 10 · 2022: 4 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 19 · 2017: 20 · 2016: 16 · 2015: 5 · 2014: 18 · 2013: 11 · 2012: 14
FWCI
10.31
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Chicago
  • Japan Science and Technology Corporation
  • National Institute of Biomedical Innovation
  • National Institutes of Health (AG 10 124)
  • Japan Society for the Promotion of Science
  • National Institute on Aging (P30AG010124, AG-10124)
  • Core Research for Evolutional Science and Technology
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
BACE1, sphingosine-1-phosphate, sphingosine kinase, amyloid-beta production, Alzheimer's disease, sphingosine kinase 2, neurons, therapeutic target
MeSH terms
Alzheimer Disease, Animals, Cells, Cultured, Cerebral Cortex, Humans, Lysophospholipids, Neurons, Sphingosine, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, RNA Interference, Mice, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review